Medicare Enrolled

Dr. Andleeb Usmani, D.O.

Dermatology · Miami, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
3100 SW 62ND AVE, Miami, FL 33155
3056685518
In practice since 2007 (19 years)
NPI: 1447393251 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Usmani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Usmani? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Usmani

Dr. Andleeb Usmani is a dermatology specialist in Miami, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Usmani performed 1,337 Medicare services across 600 unique beneficiaries.

Between the years covered by Open Payments, Dr. Usmani received a total of $7,687 from 40 pharmaceutical and/or device companies across 451 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Usmani is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 1,337 Medicare services $7,687 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,337
Medicare services
Bottom 26% in FL for dermatology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
600
Unique beneficiaries
$54
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~70 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14 403 $5 $16
Office visit, established patient (30-39 min) 171 $96 $277
Destruction of skin growths (warts/lesions), 1-14 160 $89 $251
Biopsy of related skin growth, each additional growth 153 $41 $135
Skin biopsy, tangential 129 $54 $250
Office visit, established patient (20-29 min) 97 $71 $196
Destruction of precancerous skin growth, 1 86 $35 $156
Destruction of precancer skin growth, 15 or more growths 60 $137 $392
Injection into skin growth, 1-7 growths 19 $32 $125
New patient office visit (30-44 min) 18 $71 $253
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm 15 $113 $370
New patient office visit (45-59 min) 14 $78 $330
Complicated repair of wound of trunk, 2.6-7.5 cm 12 $310 $823
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,687
Total received (2018-2024)
Avg $1,098/year across 7 years
Top 22% in FL for dermatology
40
Companies
451
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,541 (98.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$145 (1.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,617
2023
$1,661
2022
$669
2021
$699
2020
$728
2019
$1,274
2018
$1,040

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$1,204
Regeneron Healthcare Solutions, Inc.
$833
GENZYME CORPORATION
$777
Amgen Inc.
$413
LEO Pharma Inc.
$390
Novartis Pharmaceuticals Corporation
$350
VYNE Pharmaceuticals Inc.
$331
ABBVIE INC.
$326
AbbVie Inc.
$310
Surgical Specialties Corporation (US), Inc.
$261
Sun Pharmaceutical Industries Inc.
$204
AbbVie, Inc.
$197
Ortho Dermatologics, a division of Bausch Health US, LLC
$172
Pierre Fabre Pharmaceuticals, Inc.
$170
REVANCE THERAPEUTICS, INC.
$160
Incyte Corporation
$143
Lilly USA, LLC
$137
Promius Pharma LLC
$130
Paratek Pharmaceuticals, Inc.
$128
SUN PHARMACEUTICAL INDUSTRIES INC.
$119
SANOFI-AVENTIS U.S. LLC
$99
Galderma Laboratories, L.P.
$97
Merz North America, Inc.
$97
Verrica Pharmaceuticals Inc.
$78
STRATA Skin Sciences, Inc.
$72
Melinta Therapeutics, Inc.
$63
Boehringer Ingelheim Pharmaceuticals, Inc.
$56
Celgene Corporation
$51
Encore Dermatology Inc.
$43
DUSA Pharmaceuticals, Inc.
$41
Biofrontera Inc.
$41
Janssen Biotech, Inc.
$38
Merck Sharp & Dohme Corporation
$26
Dermavant Sciences, Inc.
$23
Novo Nordisk Inc
$19
Genentech USA, Inc.
$19
Mayne Pharma Inc.
$19
SANOFI US SERVICES INC.
$18
Abbott Laboratories
$16
MERZ NORTH AMERICA, INC.
$14
Top 3 companies account for 36.6% of total payments
Associated products mentioned in payments ›
ABSORICA (isotretinoin) · ADBRY · AKLIEF · AMELUZ · AMZEEQ · ARAZLO · BLU-U · Baxdela · CARDIOMEMS · CIBINQO · COSENTYX · Cabtreo · Cloderm Cream · DAXXIFY · DORYX · DUOBRII · DUPIXENT · Dermatological Psoriasis and Vitiligo Treatment · EBGLYSS · ENSTILAR · EUCRISA · Enbrel · Erivedge · HEMANGEOL · HUMIRA · Humira · ILUMYA · Ilumya · Impoyz · JUBLIA · LEVULAN KERASTICK · NUZYRA · OLUMIANT · OPZELURA · Odomzo · Otezla · REMICADE · RETIN-A-MICRO · RINVOQ · SILIQ · SIVEXTRO · SKYRIZI · SOOLANTRA · SPEVIGO · Sernivo · Sernivo Spray · Skyrizi · TALTZ · TREMFYA · VTAMA · Winlevi · XTRAC · Xeomin · YCANTH · ZILXI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $575 per 100 Medicare services performed
Looking for a dermatology specialist in Miami?
Compare dermatologists in the Miami area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
203
Per 100K population
7.6
County median income
$68,694
Nearest hospital
KERALTY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Usmani is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Usmani experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Usmani performed 403 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Usmani receive payments from pharmaceutical companies?
Yes. Dr. Usmani received a total of $7,687 from 40 companies across 451 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Usmani's costs compare to other dermatologists in Miami?
Dr. Usmani's average Medicare payment per service is $54. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Usmani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →